Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Grants & Contracts
Research output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Phase 3, Multicenter, Randomized, Partially Blinded, Palivizumab- Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for Severe RSV Disease
Wurth, Mark
(PI)
Ballard, Hubert
(CoI)
Pediatrics
Overview
Grants and Contracts Details
Status
Active
Effective start/end date
3/1/22
→
7/15/24
Funding
Merck Sharp & Dohme Corporation:
$13,735.00
View all
View less